| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| S409091-1ml | 1ml | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $43.90 |
Anti-infection Inhibitors
| Specifications & Purity | Moligand™, 10mM in DMSO |
|---|---|
| Biochemical and Physiological Mechanisms | Sulbactam is a beta-lactamase inhibitor with an average IC50 of 0.8 μM. |
| Storage Temp | Store at -80°C |
| Shipped In | Ice chest + Ice pads |
| Grade | Moligand™ |
| Product Description | Information Sulbactam Sulbactam is a beta-lactamase inhibitor with an average IC50 of 0.8 μM. In vivo
cell lines：BaF3 cells Concentrations： Incubation Time： Powder Purity:≥99% |
| Canonical SMILES | CC1(C)C(N2C(CC2=O)[S]1(=O)=O)C(O)=O |
|---|---|
| Molecular Weight | 233.24 |
Enter Lot Number to search for COA:
| Solubility | Solubility (25°C) In vitro DMSO: 13 mg/mL warmed with 50ºC Water: bath (18.42 mM); Water: Insoluble; Ethanol: Insoluble; |
|---|
| 1. Li Xiaobo, Song Yanqing, Wang Lina, Kang Guangbo, Wang Ping, Yin Huabing, Huang He. (2021) A Potential Combination Therapy of Berberine Hydrochloride With Antibiotics Against Multidrug-Resistant Acinetobacter baumannii. Frontiers in Cellular and Infection Microbiology, 11 [PMID:33842399] [10.3389/fcimb.2021.660431] |
| 1. Li Xiaobo, Song Yanqing, Wang Lina, Kang Guangbo, Wang Ping, Yin Huabing, Huang He. (2021) A Potential Combination Therapy of Berberine Hydrochloride With Antibiotics Against Multidrug-Resistant Acinetobacter baumannii. Frontiers in Cellular and Infection Microbiology, 11 [PMID:33842399] [10.3389/fcimb.2021.660431] |
